Mark J. McArthur

9.4k total citations · 1 hit paper
45 papers, 6.9k citations indexed

About

Mark J. McArthur is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark J. McArthur has authored 45 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Genetics. Recurrent topics in Mark J. McArthur's work include Cancer-related Molecular Pathways (8 papers), Virus-based gene therapy research (6 papers) and Cancer Research and Treatments (5 papers). Mark J. McArthur is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Virus-based gene therapy research (6 papers) and Cancer Research and Treatments (5 papers). Mark J. McArthur collaborates with scholars based in United States, Hungary and Australia. Mark J. McArthur's co-authors include Charles A. Montgomery, Michele Harvey, Allan Bradley, Lawrence A. Donehower, Janet S. Butel, Betty L. Slagle, Ann B. Kier, Wallace B. Baze, Friedhelm Schroeder and Andrey V. Frolov and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark J. McArthur

45 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1992 3.8k citations Lawrence A. Donehower, Michele Harvey et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. McArthur United States	26	4.3k	3.6k	1.2k	930	746	45	6.9k
Sam Thiagalingam United States	36	6.7k 1.6×	4.3k 1.2×	1.2k 1.0×	821 0.9×	1.5k 2.0×	73	9.0k
H. Earl Ruley United States	40	6.3k 1.5×	4.5k 1.2×	1.1k 1.0×	1.1k 1.2×	2.4k 3.3×	74	10.1k
Charles A. Montgomery United States	24	5.8k 1.4×	4.3k 1.2×	1.3k 1.1×	957 1.0×	1.9k 2.6×	55	10.3k
Jolene J. Windle United States	43	4.5k 1.1×	2.5k 0.7×	778 0.7×	194 0.2×	1.1k 1.5×	137	7.7k
David C. Hancock United Kingdom	29	4.0k 0.9×	1.9k 0.5×	689 0.6×	185 0.2×	518 0.7×	51	6.0k
Masuo Obinata Japan	45	4.3k 1.0×	1.5k 0.4×	435 0.4×	511 0.5×	808 1.1×	209	7.1k
Drazen B. Zimonjic United States	40	4.2k 1.0×	1.6k 0.4×	1.2k 1.0×	230 0.2×	855 1.1×	91	6.5k
Jian Chen China	44	4.4k 1.0×	1.7k 0.5×	1.8k 1.5×	175 0.2×	489 0.7×	195	8.7k
Jennifer P. Morton United Kingdom	51	5.2k 1.2×	3.9k 1.1×	2.3k 2.0×	368 0.4×	300 0.4×	100	9.5k
Richard S. Maser United States	25	5.3k 1.2×	2.0k 0.6×	1.6k 1.4×	194 0.2×	623 0.8×	34	6.8k

Countries citing papers authored by Mark J. McArthur

Since Specialization

Citations

This map shows the geographic impact of Mark J. McArthur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. McArthur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. McArthur more than expected).

Fields of papers citing papers by Mark J. McArthur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. McArthur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. McArthur. The network helps show where Mark J. McArthur may publish in the future.

Co-authorship network of co-authors of Mark J. McArthur

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. McArthur. A scholar is included among the top collaborators of Mark J. McArthur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. McArthur. Mark J. McArthur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirz, Taghreed, Irene Guijarro, Monique B. Nilsson, et al.. (2020). Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma. Cancer Prevention Research. 14(3). 313–324. 25 indexed citations

Yoon, Jung-Hoon, et al.. (2019). Error-Prone Replication through UV Lesions by DNA Polymerase θ Protects against Skin Cancers. Cell. 176(6). 1295–1309.e15. 83 indexed citations

Chen, Aaron, Yang Qiao, Jonathan O. Martinez, et al.. (2018). In vivo imaging of radiopaque resorbable inferior vena cava filter infused with gold nanoparticles. PubMed. 3. 90–90. 8 indexed citations

Wagner, Michael J., Rahul Mitra, Mark J. McArthur, et al.. (2017). Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics. 16(6). 1114–1123. 101 indexed citations

Melancon, Marites P., David Fuentes, Tian Li, et al.. (2017). Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases. Radiology. 286(1). 149–157. 19 indexed citations

Chen, Xian, Tuyen Bui, Yufeng Jiang, et al.. (2016). Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 15(4). 593–607. 51 indexed citations

Gallardo, Miguel, Hun Ju Lee, Xiaorui Zhang, et al.. (2015). hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies. Cancer Cell. 28(4). 486–499. 110 indexed citations

Eggers, M., Mark J. McArthur, Mohamed E. Abdelsalam, et al.. (2015). Pilot in vivo study of an absorbable polydioxanone vena cava filter. Journal of Vascular Surgery Venous and Lymphatic Disorders. 3(4). 409–420. 23 indexed citations

Buxhoeveden, Daniel P., Cheryl D. Stimpson, Archibald J. Fobbs, et al.. (2013). Developmental changes in the spatial organization of neurons in the neocortex of humans and common chimpanzees. The Journal of Comparative Neurology. 521(18). 4249–4259. 25 indexed citations

10.

Zhu, Feng, Martijn E.T. Dollé, Thomas R. Berton, et al.. (2010). Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes. Cancer Research. 70(14). 5851–5859. 43 indexed citations

11.

Sherwood, Chet C., Tetyana Duka, Cheryl D. Stimpson, et al.. (2010). Neocortical synaptophysin asymmetry and behavioral lateralization in chimpanzees (Pan troglodytes). European Journal of Neuroscience. 31(8). 1456–1464. 7 indexed citations

12.

Pusapati, Raju V., et al.. (2009). E2F2 suppresses Myc‐induced proliferation and tumorigenesis. Molecular Carcinogenesis. 49(2). 152–156. 37 indexed citations

13.

Wang, Aijin, et al.. (2007). Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells. Molecular Carcinogenesis. 46(6). 476–487. 25 indexed citations

14.

McArthur, Mark J., et al.. (2005). E2F3a Stimulates Proliferation, p53-Independent Apoptosis and Carcinogenesis in a Transgenic Mouse Model. Cell Cycle. 5(2). 184–190. 41 indexed citations

15.

Ciarlet, Max, Mark A. Gilger, Christopher Barone, et al.. (1998). Rotavirus Disease, but Not Infection and Development of Intestinal Histopathological Lesions, Is Age Restricted in Rabbits. Virology. 251(2). 343–360. 37 indexed citations

16.

Wertz, Philip W., et al.. (1997). Inhibition of Retinoid Signaling in Transgenic Mice Alters Lipid Processing and Disrupts Epidermal Barrier Function. Molecular Endocrinology. 11(6). 792–800. 33 indexed citations

17.

Donehower, Lawrence A., Michele Harvey, Hannes Vogel, et al.. (1995). Effects of genetic background on tumorigenesis in p53‐deficient mice. Molecular Carcinogenesis. 14(1). 16–22. 207 indexed citations

18.

Donehower, Lawrence A., Michele Harvey, Betty L. Slagle, et al.. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356(6366). 215–221. 3806 indexed citations breakdown →

19.

Watters, Dianne, Susan L. Hamilton, Mark J. McArthur, et al.. (1990). The bistratenes: new cytotoxic marine macrolides which induce some properties indicative of differentiation in HL-60 cells. Biochemical Pharmacology. 39(10). 1609–1614. 16 indexed citations

20.

McArthur, Mark J., et al.. (1988). Fatty acid activation of protein kinase C: Dependence on diacylglycerol. Biochemical and Biophysical Research Communications. 152(2). 825–829. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact